SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-009381
Filing Date
2020-08-05
Accepted
2020-08-05 16:01:05
Documents
14
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K coll-20200805x8k.htm   iXBRL 8-K 44484
2 EX-99.1 coll-20200805xex99d1.htm EX-99.1 200069
3 GRAPHIC coll-20200805xex99d1001.jpg GRAPHIC 3682
  Complete submission text file 0001558370-20-009381.txt   386564

Data Files

Seq Description Document Type Size
4 EX-101.SCH coll-20200805.xsd EX-101.SCH 3281
5 EX-101.LAB coll-20200805_lab.xml EX-101.LAB 16164
6 EX-101.PRE coll-20200805_pre.xml EX-101.PRE 10952
7 EXTRACTED XBRL INSTANCE DOCUMENT coll-20200805x8k_htm.xml XML 4835
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 201077134
SIC: 2834 Pharmaceutical Preparations